- Journalists Distill News on Ebola, Licensing Midwives, and California’s Budget
- Justice Department charges 15 for $90M+ in alleged healthcare fraud, expands strike force
- UnitedHealth’s PBM names CFO
- Tennessee becomes 2nd state to ban PBMs from owning pharmacies
- Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
- 40% lower physician distress, 245% more violence reporting: Workforce retention strategies gaining traction
- 15 new behavioral health study findings to know
- APRN charged in $1.35M Medicare fraud scheme
- Florida woman faces charges of practicing unlicensed dentistry
- GI of the Rockies launches AI-powered care program
- Deputy injured in Indiana hospital shooting
- Legacy Health-backed insurer PacificSource to exit ACA market, pull out of Montana entirely
- Expanded federal scrutiny reshapes how hospitals govern risk, compliance
- The instability compounding the anesthesiologist shortage
- ADA proposes standards on dental cartridges, water quality
- The unraveling of prior authorization: 5 things to know
- The hospital bad debt and charity care crisis: 20 things to know
- As AI identifies more at-risk patients, health systems face a capacity challenge
- 5 GI power players
- 4 dental insurance updates to know
- Federal appeals court overturns EPA fluoride ruling: 5 notes
- What payers don’t understand about ASC spine surgery
- 3 men sentenced for $6.9M orthotic DME fraud scheme
- What will outpatient cardiology look like in 10 years?
- 15 leadership moves across 4 specialties
- Dental Medicaid disenrollment could cause $86M in added costs
- Park Dental opens Minnesota practice
- AI is about to break healthcare’s scarcity model — if we let it
- The most underrated threat in digital health
- Tennessee orthodontic practice opens 2 locations
- Justice Department charges autism care providers in $46.6M fraud case
- 14.2% of Medicaid patients received mental health ED follow-up: 4 notes
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Leaders sound off on overrated ASC trends
- Dental hygienist employment reaches 222,000: State-by-state breakdown
- Vitana Pediatric & Orthodontic Partners adds 1st Maryland practice
- 10 highest-paying states for dental hygienists in 2026
- US overdose deaths decline for 3rd straight year: What it means for healthcare
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- ACAP warns final ACA rule adds further uncertainty to a market in flux
- AbbVie plots 85 summer layoffs tied to Allergan unit in California
- Quorum Health transitioning to nonprofit for financial pickup
- Women's Health Capitol Hill Day: Advocates lobby to advance budget priorities
- Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm
- Novartis, AbbVie plan summer layoffs on opposite coasts
- AstraZeneca, Daiichi beat Gilead to first-line TNBC with FDA nod for Datroway
- Industry Voices—From claims to compassion: Reclaiming patient advocacy in revenue cycle
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- AbbVie, GSK race up patient reputation leaderboard in the UK
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- Trump’s $50B Rural Health Bet Meets a Healthcare Desert in North Carolina
- 3 Medical Routines That Older People May Not Need
- Fierce Pharma Asia—Merck-Kelun ADC’s triple wins; Tools in China licensing deals; Takeda’s $885M antitrust loss
- Tyra creates awareness day with patient advocates to shine light on a rare cancer
- Machine learning-guided lifestyle plans reduce depression symptoms: 3 study notes
- Innovaccer picks up CaduceusHealth to offer end-to-end revenue cycle management
- Acadia psychiatric hospital faces abuse lawsuits
- Massachusetts behavioral health clinics to pay $1.4M to settle fraud allegations
- From 50 days to 7: How 1 system cut behavioral health intake wait times
- Hospitals allege contracted CVS Health subsidiaries pocketed their 340B savings
- Northwell hospital launches in-home behavioral health services
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Ksana Health awarded $17.9M to build behavioral health foundation model
- Lilly accuses church-linked pharmacies, wholesalers and more of running $200M+ rebate fraud scheme
- Study: Brokers increasingly recommending ICHRA to employers
- ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer
- Common Food Preservatives Linked to Major Heart Problems
- Health Tech Weekly Rundown: Prime Healthcare expands virtual sitting tech; CVS Health studies seniors' digital health needs
- Amgen's Tavneos, facing liver injury scrutiny, gets label update in Japan as patient starts resume
- Gilead pledges 400K AmBisome doses to fight visceral leishmaniasis in expanded WHO collab
- With Voxzogo under pressure, BioMarin touts trial win in label expansion bid
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Religious Anti-Abortion Center Finds Opportunity In Town Without OB-GYNs
- CPAP Insurance Rules Too Stringent, Deny Device Coverage To Sleep Apnea Patients Who Would Benefit
- ICE Arrests Are Separating Families. Here’s How To Plan Ahead.
- Colorado Charts Its Own Course on Vaccines Amid Federal Pullback
- OpenEvidence launches hands-free voice AI feature, expands hospital footprint with Cedars-Sinai tie-up
- Inside agency view: Ogilvy Health on AI’s ‘light speed,’ nano influencers and the rise of Ria
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Kennedy dismisses leaders of US Preventive Services Task Force
- Statement on Novel Exchange-Traded Funds (ETFs)
- CMS proposes rule aimed at limiting Medicaid state-directed payments
- WTW: Employers aiming to bulk up AI use for health and benefits
- Freestanding EDs, urgent care acquisition opportunities abound for HCA Healthcare
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- 'Missed risk': Women's Heart Health Summit explores gaps in research, treatment
- House and Senate Democrats move to overturn CMS’ WISeR AI prior auth pilot
- Designing an agentic, future‑ready tech roadmap for emerging pharma
- Judi Health taps Clear for its identity verification tech
- Canvas Medical unveils Canvas Studio, a customizable EMR workflow tool for clinicians
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- How specialty practices can get more out of technology investments
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Your Handwriting Could Be a Window Into Your Aging Brain
- Democratic senators share plans for Medicare home care benefit, long-term care reform
- GHO Capital, CBC Group plan to merge, forming $21B healthcare investment firm
- Ipsen details growing pains as teens transition to adult care
- Lilly, AbbVie, J&J, AZ lead an uptick in Big Pharma Q1 growth, with Novo again bringing up the rear
- MetroHealth partners with Artisight on smart hospital platform rollout
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
- BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
- Gilead inks another deal with Korean API manufacturer Yuhan, this time worth $140M
- Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Amgen, bidding adieu to CFO, lures Galderma exec with hefty $12.4M bonus
- Watch: The Tug-of-War Over Taxpayer Dollars
- Religious Anti-Abortion Center Finds Opportunity in Town Without OB-GYNs
- CG Life appoints Collette Douaihy as chief creative officer as C-suite buildout continues
- Tarsus taps John Cena for its latest Demodex blepharitis campaign
- Statement on Proposing Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- American Aid Worker Tests Positive for Ebola After DRC Exposure
- Listen to the Latest ‘KFF Health News Minute’
- Headache Medicine: Statement on Proposing Releases for Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- More Kids Seeking Anxiety Help at Routine Doctor Visits, Study Finds
- Statement on Proposing Releases for Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies, and Registered Offering Reform
- Global MedTech Contract Manufactures Finalize Merger
- Global MedTech Contract Manufactures Finalize Merger
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Boston Scientific announces strategic investment in MiRus LLC
- Boston Scientific announces strategic investment in MiRus LLC
- Weed/Opioid Combo Doesn't Help Knee Arthritis Pain
- Losing A Parent Can Dent An Adult's Earning Power
- Ticks Can Creepy-Crawl Your House For Weeks Before Dying, Study Shows
- Kids Keep Getting Stuck in Hospitals, Even After Being Cleared For Discharge
- Short, Intense Radiation Therapy Safe For Prostate Cancer Patients
- Efforts To Understand the Nation’s Drugged Driving Problem Stall Under Trump
- Somewhere Between Cacophony and Euphony
- Ebola Outbreaks in Africa Trigger Global Health Emergency, U.S. Travel Warnings
- Rapid Weight Loss Beats Slow and Steady in New Clinical Trial
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Smog Linked To Lewy Body Dementia Risk, Major Study Finds
- NYC Mold Removal Program Cut Asthma ER Cases By A Quarter, Study Says
As usual, politics in 2024 is an upside-down world. He said, she said, who knows where the truth lives amid the lies?
The Gateway Pundit published one of the clearest statements I've seen yet regarding the presidential candidates and their positions on abortion.
Practical federalism at its finest.
https://www.thegatewaypundit.com/2024/08/frank-pavone-lets-stop-asking-wrong-questions-about/
Quote]
Frank Pavone: Let’s Stop Asking the Wrong Questions About Trump and Abortion
Recent headlines are all about Vice Presidential candidate J.D. Vance predicting on a Sunday morning talk show that, if re-elected, President Donald Trump would veto any national bill banning abortion.
As is so often the case with the legacy media, they were asking the wrong question.
So asking a question like NBC’s Kristen Welker asked is setting up a scenario that is totally devoid of reality.
Another unlikely scenario is a Democrat-controlled Congress sending to Trump the Women’s Health Protection Act, a radical piece of legislation that would undo every pro-life law in the nation.
I wonder why they didn’t ask about that.
I am still waiting for the interview in which the media ask about the actual pro-life measures that will be within the President’s power from day one, all of which he did in his first term. For instance:
- Will you reinstate the expanded Mexico City policy, which so efficiently kept U.S. tax dollars from flowing to abortion profiteers overseas?
- Will you reinstate the rule barring any organization that receives Title X funds for family planning from discussing abortion with their clients?
- Will you continue to appoint federal judges who understand that the right to life is fundamental to our Constitution?
- Will you have the United States once again sign on to the life-affirming Geneva Consensus Declaration?
- Will you again defund the U.N. Population Fund (UNFPA), which peddles abortion ideology in 150 nations?
- Will you reinstate the office of Conscience and Religious Freedom within the Department of Health and Human Services?
But, of course, the Trump-hating media are not interested in making the President seem reasonable to pro-life and pro-choice people alike, by reminding them that he supports pro-life measures that most Americans likewise support.
Anti-Trumpers don’t want to remind pro-life people of what he actually accomplished, because that might encourage rather than suppress the pro-life vote.
We already have the tools we need to change public policy in a second Trump term to better protect the unborn.
We need freedom of speech, so we can educate people on abortion; freedom of religion to activate churches to protect the unborn; freedom of assembly to allow for pro-life marches, rallies, protests and prayer vigils; and, importantly, existing pro-life laws, which actually keep some money away from abortion businesses and protect some babies.
These tools already are in our arsenal, but the Democrats want to take them away from us. They’re throwing peaceful pro-lifers in prison, censoring pro-life speech, trying to shut down pregnancy centers and canceling pro-life politicians.
President Trump is the best person to protect the tools we need in order to end abortion. We don’t need him to give pro-life speeches or commit to signing bills – like a national ban on abortion – that aren’t going to come to his desk in the first place.
We have to get him elected, because if the Democrats have their way, the pro-life movement will not have the political freedom to protect any babies.
And yet here we are, over the weekend and today, arguing on social media and in the press about whether we can support President Trump because, as some say, he’s “backing away” from the pro-life position.
In reality, the choice before us is not between President Trump and somebody better. It’s between President Trump and somebody worse. It’s between President Trump, who made it possible for states to protect the unborn, as many of them now do and will continue to do, and Kamala Harris, who wants to take away the ability of states to protect the unborn by making abortion a fundamental constitutional right.
I often say that mothers do not choose abortion because they have freedom of choice, but because they have no freedom and no choice. In this election, if we want to preserve our freedom to protect life, there is only one choice.
This Daily Signal commentary defends federalist strategy + pro-life goals in a way I haven't seen elsewhere. I like it: it makes me feel conservatives are regaining some of the ground that is their constitutional heritage.
https://www.dailysignal.com/2024/11/15/3-pro-life-policies-watch-trumps-second-term/
3 Pro-Life Policies to Watch for in Trump’s Second Term
Donald Trump is the most pro-life president in U.S. history. No other leader of the free world has matched his commitment to defending life, from defunding abortion providers to decisively reshaping the Supreme Court.
As we look to a second Trump term, two pro-life policies are likely to take center stage and immediately should be adopted.
A third—a national abortion ban—is not likely to get traction at this time.
1. Defund Planned Parenthood
Under President Joe Biden, Planned Parenthood received a record $750 million of taxpayer funding while performing a record 392,000 abortions just last year. The so-called nonprofit now gets roughly one-third of its total income from the federal government.
Defunding Planned Parenthood would be a major setback for the organization, which has already shown signs of mission drift and ineffective leadership in the post-Roe v. Wade era.
Since Cecile Richards left in 2018 after 12 years at the helm, the role of CEO at Planned Parenthood has become a chaotic evolving door, and the overturning of Roe didn’t help. The current leadership has been less effective in executing Planned Parenthood’s mission, as confirmed by both current and former employees.
In 2017, Trump sought to defund Planned Parenthood, but was blocked by then-Speaker of the House Paul Ryan and other Republicans lacking the political will and moral clarity to make it happen.
He revisited the idea in 2019 through Title X, which provides government funding to Planned Parenthood to distribute contraceptives and other so-called family planning. Just last month, shortly before the election, then-vice presidential candidate Sen. JD Vance, R-Ohio, affirmed the Republican ticket’s goal to defund Planned Parenthood under a second Trump administration.
This move also aligns with Trump’s stance that abortion is now a state issue and, therefore, federal funding should not be supporting it. Like many other nonprofits in the nation, Planned Parenthood should fund itself, rather than relying on federal handouts.
Additionally, we can expect Trump to both cut funding for Planned Parenthood International—Planned Parenthood’s arm in foreign countries—as he did in his first term, and reinstate the Mexico City Policy, one of his first actions as president in 2017, to prevent U.S. taxpayer dollars from funding overseas abortions.
2. Reregulating Abortion Pills
Following the overturning of Roe, the Centers for Disease Control and Prevention and the Food and Drug Administration dramatically expanded access to abortion pills by permitting them to be dispensed through pharmacies and even by mail, without requiring any in-person medical oversight.
Removing the need for a visit to a medical professional before taking these pills hardly qualifies as safe health care, likely contributing to the fact that 1 out of every 21 women who take them end up in the emergency room.
Reinstating basic regulations on abortion pills is a commonsense measure that even pro-abortion advocates once supported. Not least given the revelation of alarming medical statistics, it stands a strong chance of gaining traction with a Republican majority in Congress.
3. A National Abortion Ban
Since the Supreme Court chose not to apply the 14th Amendment to unborn children, abortion has been returned to the states. Although a federal abortion ban was quickly brought into the conversation, Trump has consistently stated he would not pursue one, and there’s no reason to expect he’d go back on his word.
Calls for a 15-week ban—an arbitrary gestational threshold—were considered, but ultimately rejected, by Trump. In a post-Roe America, where 25 states have already enacted strong pro-life laws, a 15-week ban would undermine their more protective legislation already in place, signaling weakness rather than progress. A 15-week ban would become the standard in all of those pro-life states that have already saved tens of thousands of babies with stricter bans or heartbeat bills that prevent abortions after six weeks of pregnancy.
Trump is sometimes accused of not listening to advisers, but the pro-life movement’s experience has shown otherwise. As a candidate, Trump admitted his limited knowledge of abortion, but took the time to educate himself. He listened to pro-life champions and accepted critical guidance from Federalist Society Chairman Leonard Leo and other Catholic leaders on Supreme Court nominations. This led directly to the overturning of Roe, an event many pro-life Americans never thought they’d witness.
In a second term, Trump is poised to remain a steadfast pro-life president. While pro-life Americans shouldn’t give him a free pass, it would be reckless and disrespectful to ignore his remarkable record.
Trump has demonstrated his commitment to the pro-life cause, and there’s every reason to believe he will govern with those values at the forefront once again.
Shawn Carney is president and CEO of the pro-life organization 40 Days for Life and the author of “What to Say When 2: Your Proven Guide in the New Abortion Landscape.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















